Related Experiment Video
Updated: Mar 15, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.6K
Increasing adherence to topical therapy in psoriasis through use of solution medication
Dane Hill, Michael E Farhangian, Steven R Feldman1
1Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine Department of Pathology, Wake Forest School of Medicine Department of Public Health Sciences, Wake Forest School of Medicine. sfeldman@wakehealth.edu.
Dermatology Online Journal
|September 13, 2016
Summary
Improving adherence to topical psoriasis treatments is key for better patient outcomes. Strategies include choosing the right medication vehicle and involving support systems to enhance convenience and efficacy.
Area of Science:
- Dermatology
- Pharmacology
- Patient Adherence Research
Background:
- Topical medication adherence significantly impacts patient outcomes, particularly in chronic dermatological conditions like psoriasis.
- A notable proportion of patients (approximately 20%) express dissatisfaction with the convenience of topical treatments, affecting adherence.
- Psoriasis management often relies on topical therapies, making adherence a critical factor for clinical improvement.
Discussion:
- Healthcare providers play a crucial role in enhancing topical medication adherence.
- Strategies include optimizing medication vehicle selection for improved usability and patient acceptance.
- Educating patients on potential side effects before treatment initiation can proactively address concerns and foster trust.
Key Insights:
- Patient-provider communication regarding medication convenience and potential side effects is vital.
- Involving family members or friends in the application process can serve as a practical support mechanism.
- Tailoring treatment approaches to patient convenience can directly influence adherence rates.
Outlook:
- Enhanced adherence to topical psoriasis treatments is anticipated to lead to superior disease control.
- Future research could explore novel drug delivery systems to further improve topical therapy convenience.
- Long-term studies are needed to quantify the direct correlation between improved adherence strategies and sustained psoriasis remission.
Related Concept Videos
01:28Drug Therapy
364
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
364
01:27Bioavailability Enhancement: Drug Permeability Enhancement
291
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
291
01:23Ophthalmic Drug Delivery Systems
154
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
154
01:18Transdermal Drug Delivery Systems
94
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
94
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
307
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
307
01:16Bioavailability Enhancement: Drug Solubility Enhancement
414
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
414